SOPHARMA AD: Current report 88 buy back 27092016

opublikowano: 2016-09-27 14:39

Spis treści:

2. INFORMATION ABOUT THE ENTITY

3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Spis załącznikĂłw:
Current_report_88_buy_back_27092016.doc (REPORT)

	POLISH FINANCIAL SUPERVISION AUTHORITY
				UNI - EN REPORT No		88	/	2016
	Date of issue:		2016-09-27
	Short name of the issuer
	SOPHARMA AD
	Subject
	Current report 88 buy back 27092016
	Official market - legal basis
	art. 17. 1 MAR.
	Unofficial market - legal basis
	Contents of the report:
	SOPHARMA AD hereby informs that from 15 September up to and including 26 September 2016 the Company bought 27 669 own shares representing 0.02% of the share capital of the Company, at a total value of 77 250.62 BGN on the Bulgarian Stock Exchange, the average price per share was 2.79 BGN. The trading of treasury shares is pursuant to decision by the Annual General Meeting of Shareholders from 23 June 2010. The total number of treasury shares after these transactions is 5 507 381, representing 4.085% of the share capital of the Company.
	Annexes
	File				Description
	Current report 88 buy back 27092016.docCurrent report 88 buy back 27092016.doc				Current report 88 buy back 27092016

SOPHARMA AD

(fullname of the issuer)

SOPHARMA AD

Farmaceutyczny (far)

(short name of the issuer)

(sector according to clasification
of the WSE in Warsow)

1220

Sofia

(post code)

(city)

IlienskoShosse

16

(street)

(number)

+359 2 813 42 00

+359 2 936 02 86

(phone number)

(fax)

(e-mail)

(web site)

nd

(NIP)

(REGON)

	SIGNATURE OF PERSONS REPRESENTING THE COMPANY
	Date	Name	Position / Function	Signature
	2016-09-27	Ognian Donev	Executive director